PLRX FY 2024 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$228M

Net Income

-$210M

EPS (Diluted)

$-3.47

Cash Flow

Operating Cash Flow

-$156M

Free Cash Flow

-$159M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$397M

Total Liabilities

$93M

Stockholders' Equity

$304M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	$0	$2M	-100.0%
Operating Income	-$228M	-$184M	-24.0%
Net Income	-$210M	-$161M	-30.4%